Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
Assunto da revista
País de afiliação
Intervalo de ano de publicação
1.
Dermatol Ther ; 33(1): e13150, 2020 01.
Artigo em Inglês | MEDLINE | ID: mdl-31670893

RESUMO

Paradoxical reactions during treatment with biological agents may be defined as an appearance or exacerbation of a pathological condition that usually responds to this class of drug. Typical examples of paradoxical adverse effect are, among others, palmoplantar pustular and psoriasiform reactions or HS, in patients during a treatment of rheumatoid arthitis or IBD mainly. A few reports have been described an exacerbation of psoriasis1, palmoplantar pustular, or pustular psoriasis eruption with secukinumab. Marasca et al. highlights the immunological complexity that surrounds autoinflammatory diseases showing the potential double pathogenetic face of secukinumab in HS, describing a case of secukinumab-induced HS and a case of HS caused by adalimumab treatment and controlled by secukinumab therapy. Real world evidence and results from clinical trials with secukinumab for HS, will possibly show the real role that anti-IL-17 drugs play in this complex disease.


Assuntos
Anticorpos Monoclonais Humanizados/efeitos adversos , Fármacos Dermatológicos/efeitos adversos , Hidradenite Supurativa/induzido quimicamente , Anticorpos Monoclonais Humanizados/administração & dosagem , Artrite Psoriásica/tratamento farmacológico , Fármacos Dermatológicos/administração & dosagem , Humanos , Masculino , Pessoa de Meia-Idade , Psoríase/tratamento farmacológico
2.
Reumatol Clin ; 13(2): 85-90, 2017.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-27068194

RESUMO

OBJETIVE: To describe (structure, processes) of the multidisciplinary care models in psoriatic arthritis (PsA) in Spain, as well as barriers and facilitators of their implementation. METHODS: A qualitative study was performed following structured interviews with 24 professionals (12 rheumatologists, 12 dermatologists who provide multidisciplinary care for patients with PsA). We collected data related to the hospital, department, population and multidisciplinary care model (type, physical and human resources, professional requirements, objectives, referral criteria, agendas, protocols, responsibilities, decision- making, research and education, clinical sessions, development and planning of the model, advantages and disadvantages of the model, barriers and facilitators in the implementation of the model. The models characteristics are described. RESULTS: We analyzed 12 multidisciplinary care models in PsA, with at least 1-2 years of experience, and 3 subtypes of models, face-to-face, parallel, and preferential circuit. All are adapted to the hospital and professionals characteristics. A proper implementation planning is essential. The involvement and empathy between professionals and an access and well-defined referral criteria are important facilitators in the implementation of a model. The management of agendas and data collection to measure the multidisciplinary care models health outcomes are the main barriers. CONCLUSIONS: There are different multidisciplinary care models in PsA that can improve patient outcomes, system efficiency and collaboration between specialists.


Assuntos
Artrite Psoriásica/terapia , Dermatologia/organização & administração , Comunicação Interdisciplinar , Equipe de Assistência ao Paciente/organização & administração , Reumatologia/organização & administração , Atitude do Pessoal de Saúde , Dermatologia/métodos , Humanos , Entrevistas como Assunto , Modelos Organizacionais , Avaliação de Processos em Cuidados de Saúde , Pesquisa Qualitativa , Qualidade da Assistência à Saúde/organização & administração , Reumatologia/métodos , Espanha
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA